These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3137083)

  • 1. Effect of 1,25-dihydroxyvitamin D3 (calcitriol) on prolactin secretion at rest and TRH-stimulated secretion in humans.
    Zofková I; Nedvídková J
    Exp Clin Endocrinol; 1988 May; 91(2):207-11. PubMed ID: 3137083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1.25 (OH)2 vitamin D3 (calcitriol) on TRH-induced thyrotropin secretion in man.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1988 Mar; 91(1):7-12. PubMed ID: 3131152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the interaction of calcitonin and 1,25(OH)2-vitamin D3 on prolactin secretion.
    Zofková I; Nedvídková J
    Exp Clin Endocrinol; 1988 Mar; 92(3):262-7. PubMed ID: 2855317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 enhances thyrotropin releasing hormone induced thyrotropin secretion in normal pituitary cells.
    D'Emden MC; Wark JD
    Endocrinology; 1987 Sep; 121(3):1192-4. PubMed ID: 3113918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcitonin, 1,25(OH)2 vitamin D3 and trifluoperazine on thyrotropic secretion and their mutual interactions.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1988 Mar; 92(3):268-74. PubMed ID: 3150956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion.
    d'Emden MC; Wark JD
    In Vitro Cell Dev Biol; 1991 Mar; 27A(3 Pt 1):197-204. PubMed ID: 1903381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of stimulating effect on thyrotropic and lactotropic secretion during prolonged calcitriol administration.
    Zofková I; Táborský P; Bednár J; Nedvídková J
    Exp Clin Endocrinol; 1992; 99(1):54-6. PubMed ID: 1628699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcaemia and calcitonin inhibit prolactin secretion.
    Zofková I; Nedvídková J
    Exp Clin Endocrinol; 1984 Dec; 84(3):294-8. PubMed ID: 6441727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifluoperazine inhibits thyrotropin-releasing hormone-stimulated TSH secretion.
    Zofková I; BednárJ
    Horm Metab Res; 1986 Sep; 18(9):621-4. PubMed ID: 3096861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells.
    Atley LM; Lefroy N; Wark JD
    J Endocrinol; 1995 Dec; 147(3):397-404. PubMed ID: 8543909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.
    Verbeelen D; Vanhaelst L; Fuss M; Van Steirteghem AC
    J Endocrinol Invest; 1985 Apr; 8(2):103-6. PubMed ID: 3928730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1,25-dihydroxyvitamin D3 on rat pituitary prolactin release.
    Törnquist K
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):459-64. PubMed ID: 3425161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zinc administration on thyrotropin releasing hormone-stimulated prolactinemia in healthy men.
    Castro AV; Mendonça BB; Bloise W; Shuhama T; Brandão-Neto J
    Biometals; 1999 Dec; 12(4):347-52. PubMed ID: 10816735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxycholecalciferol enhances both the bombesin-induced transient in intracellular free Ca2+ and the bombesin-induced secretion of prolactin in GH4C1 pituitary cells.
    Törnquist K
    Endocrinology; 1991 Apr; 128(4):2175-82. PubMed ID: 1900787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intranasally sprayed synthetic TRH on TSH and on PRL secretion in children.
    Borkenstein MH
    Eur J Pediatr; 1983 Mar; 140(1):17-8. PubMed ID: 6409614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic effects of 1,25-dihydroxyvitamin D3 on the pituitary-hypothalamic axis in rats.
    Törnquist K; Lamberg-Allardt C
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):225-8. PubMed ID: 3111137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A permissive role for extracellular Ca2+ in regulation of prolactin production by 1,25-dihydroxyvitamin D3 in GH3 pituitary cells.
    Haug E; Bjøro T; Gautvik KM
    J Steroid Biochem; 1987 Oct; 28(4):385-91. PubMed ID: 2889849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
    Jeppsson S; Nilsson KO; Rannevik G; Wide L
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.